IMP was isolated in a yeast two-hybrid screen for proteins that interact with activated Ras, where binding was specific for Ras and not observed with other Ras family members. IMP is also known as BRAP2 and was originally discovered as a protein that associates with the nuclear localization motifs of the breast cancer tumor suppressor protein BRCA1 [5]; however, the functional significance of this interaction is unknown. IMP is a ubiquitously expressed, highly conserved protein, with one ortholog present in all eukaryotes examined [4,5]. All IMP proteins contain three conserved structural motifs -a RING-H2 domain followed by a ubiquitin-protease-like zinc finger (UBP-ZnF; also known as a PAZ domain) and leucine heptad repeats that are predicted to form a coiled coil. As would be expected for a Ras effector, Matheny et al. . In response to stimulus, the protein phosphatase PP2A dephosphorylates one of these sites, resulting in the release of 14-3-3, the rapid translocation of KSR to the plasma membrane, and exposure of KSR's MAP kinase binding site [14] . The end result is that KSR delivers MEK to activated Raf at the plasma membrane, provides a docking platform for ERK, and facilitates the sequential phosphorylation events required for ERK activation.
When Matheny and coworkers
examined the effect of IMP on Ras signaling, they found that instead of cooperating with other effectors to promote Ras signaling, IMP appeared to inhibit signal transmission through the Raf-MEK-ERK cascade. Overexpression of IMP blocked Raf-dependent activation of MEK and ERK without preventing activation of Raf itself; this inhibition could be circumvented by constitutively active MEK. IMP overexpression also prevented the mitogeninduced association of Raf and MEK, indicating that high IMP levels had uncoupled Raf from its downstream substrate. Providing further evidence that IMP was an antagonist of Raf-1 signaling, depletion of IMP in mammalian cells increased the amplitude of stimulus-induced ERK activation. Thus, IMP can be added to the growing list of molecules that negatively regulate Raf-MEK-ERK signaling, a list that already includes the Raf kinase inhibitor protein RKIP [6] , RIN1 [7] and Sprouty/SPRED [8, 9] . Surprisingly, the inhibitory effect of IMP was not mediated by a direct interaction with Raf, MEK or ERK. Matheny and coworkers [4] found no evidence that IMP associated with or ubiquitinated Raf, MEK or ERK, and the cellular levels of these potential targets were unaltered by IMP overexpression. Instead, IMP appears to uncouple signal transmission from Raf to MEK by inactivating an important scaffolding protein of the Ras pathway, namely the kinase suppressor of Ras (KSR) [10] [11] [12] . In normal unstimulated cells, KSR constitutively associates with MEK and is retained in the cytoplasm through the binding of a dimer of 14-3-3 proteins to two phosphoserine sites [13] . In response to stimulus, the protein phosphatase PP2A dephosphorylates one of these sites, resulting in the release of 14-3-3, the rapid translocation of KSR to the plasma membrane, and exposure of KSR's MAP kinase binding site [14] . The end result is that KSR delivers MEK to activated Raf at the plasma membrane, provides a docking platform for ERK, and facilitates the sequential phosphorylation events required for ERK activation.
Evidence that KSR is the target of IMP's inhibitory effect was obtained using fibroblasts from KSR-deficient mice [15] . Reintroduction of exogenous KSR into these cells leads to enhanced levels of stimulusinduced ERK activation, which is completely abolished by IMP overexpression. IMP associates with KSR and, when overexpressed, causes hyperphosphorylation and mislocalization of KSR into a detergent-insoluble fraction. These effects resemble those observed previously for an inactive KSR mutant that is unable to bind MEK [16] 
